Cargando…
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
Despite the fact that significant advances in treatment of common cancers have been achieved over the years, orphan tumors still represent an important unmet medical need. Due to their complex multifactorial origin and limited number of cases, such pathologies often have very limited treatment optio...
Autores principales: | Listro, Roberta, Stotani, Silvia, Rossino, Giacomo, Rui, Marta, Malacrida, Alessio, Cavaletti, Guido, Cortesi, Michela, Arienti, Chiara, Tesei, Anna, Rossi, Daniela, Giacomo, Marcello Di, Miloso, Mariarosaria, Collina, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338850/ https://www.ncbi.nlm.nih.gov/pubmed/32695745 http://dx.doi.org/10.3389/fchem.2020.00495 |
Ejemplares similares
-
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
por: Tesei, Anna, et al.
Publicado: (2019) -
Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model
por: Cortesi, Michela, et al.
Publicado: (2020) -
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
por: Listro, Roberta, et al.
Publicado: (2022) -
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
por: Tesei, Anna, et al.
Publicado: (2022) -
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
por: Malacrida, Alessio, et al.
Publicado: (2023)